- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Siemens taps Requardt to head MR unit
German multimodality vendor Siemens has appointed Hermann Requardt as general manager of itsMR division, effective in January. Requardt replaces Tom Miller,who returned to the U.S. last year when he was appointed vicepresident of imaging systems at the
German multimodality vendor Siemens has appointed Hermann Requardt as general manager of itsMR division, effective in January. Requardt replaces Tom Miller,who returned to the U.S. last year when he was appointed vicepresident of imaging systems at the company's U.S. subsidiaryin Iselin, NJ (SCAN 12/14/94).
Requardt is a 10-year Siemens veteran who has worked in thecompany's MR coils business for much of his career at the vendor.Requardt said one of his priorities is to continue the momentumgenerated by Miller, who streamlined the MR division's operations.
"Tom Miller created a lot of momentum. He establisheda decrease in hierarchical thinking and empowered a teamwork approach,"Requardt told SCAN. "Since I came to MR it has been a consolidationof what Miller really kicked off."
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
